Is the EORTC QLQ-C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?

Autor: Oort, Quirien, Zwinkels, Hanneke, Koekkoek, Johan A. F., Vos, Maaike J., Reijneveld, Jaap C., Taphoorn, Martin J. B., Dirven, Linda
Přispěvatelé: Neurology, CCA - Cancer Treatment and quality of life
Rok vydání: 2021
Předmět:
Zdroj: Psycho-Oncology, 31(6), 995-1002. John Wiley and Sons Ltd
Psycho-Oncology, 31(6), 995-1002. WILEY
Oort, Q, Zwinkels, H, Koekkoek, J A F, Vos, M J, Reijneveld, J C, Taphoorn, M J B & Dirven, L 2022, ' Is the EORTC QLQ-C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder? ', Psycho-Oncology, vol. 31, no. 6, pp. 995-1002 . https://doi.org/10.1002/pon.5889
ISSN: 1099-1611
1057-9249
DOI: 10.1002/pon.5889
Popis: Background: Screening glioma patients regularly for possible mood disorders may facilitate early identification and referral of patients at risk. This study evaluated if the EORTC QLQ-C30 Emotional Functioning (EF) scale could be used as an initial screening measure to identify patients possibly having a mood disorder. Methods: EORTC QLQ-C30 EF and Hospital Anxiety and Depression Scale (HADS) scores were collected as part of a study assessing the impact of timing of patient-reported outcome assessments on actual health-related quality of life outcomes (N = 99). Spearman correlations and Mann-Whitney U tests were used to determine the association between the EF and HADS (sub)scales. Receiver Operating Characteristic analyses were performed to determine optimal cut-off EF scores to identify patients possibly having a mood disorder (i.e. HADS subscale score ≥8 points). Results: EF and HADS (sub)scales correlated moderately (HADS-A: r = −0.65; HADS-D: r = −0.52). Significant EF score differences were found between patients with HADS ≥8 versus
Databáze: OpenAIRE
Externí odkaz: